LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Trocha, Andrzej M"
  2. AU="Smits, Anthal I P M"
  3. AU=Milton Ross D.
  4. AU="Mónica Lopes-Marques"
  5. AU="Olasińska-Wiśniewska, Anna"
  6. AU="Michel, Alexander"
  7. AU="Ku, Chin-Jen"
  8. AU="Potts, Daniel"
  9. AU="Liu, Xiang"
  10. AU="Mire, Erik"
  11. AU="Ching-Yi Hu"

Search results

Result 1 - 1 of total 1

Search options

Article: 3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone as a potent and orally active cyclooxygenase-2 selective inhibitor: synthesis and biological evaluation.

Khanapure, Subhash P / Augustyniak, Michael E / Earl, Richard A / Garvey, David S / Letts, L Gordon / Martino, Allison M / Murty, Madhavi G / Schwalb, David J / Shumway, Matthew J / Trocha, Andrzej M / Young, Delano V / Zemtseva, Irina S / Janero, David R

Journal of medicinal chemistry

2005  Volume 48, Issue 11, Page(s) 3930–3934

Abstract: Incorporation of a spacer group between the central scaffold and the aryl ring resulted in a new cyclooxygenase-2 (COX-2) selective inhibitor core structure, 3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone (20), with COX-2 IC50 = ...

Abstract Incorporation of a spacer group between the central scaffold and the aryl ring resulted in a new cyclooxygenase-2 (COX-2) selective inhibitor core structure, 3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone (20), with COX-2 IC50 = 0.25 microM and COX-1 IC50 = 14 microM (human whole blood assay). Compound 20 was orally active in the rat air pouch model of inflammation, inhibiting white blood cell infiltration and COX-2-derived PG production. Our data support the identification of a novel COX-2 selective inhibitor core structure exemplified by 20.
MeSH term(s) Administration, Oral ; Animals ; Carrageenan ; Cyclooxygenase 2 ; Cyclooxygenase 2 Inhibitors ; Cyclooxygenase Inhibitors/chemical synthesis ; Cyclooxygenase Inhibitors/chemistry ; Cyclooxygenase Inhibitors/pharmacology ; Dinoprostone/antagonists & inhibitors ; Dinoprostone/biosynthesis ; Inflammation/chemically induced ; Inflammation/metabolism ; Male ; Prostaglandin-Endoperoxide Synthases/metabolism ; Pyridines/chemical synthesis ; Pyridines/chemistry ; Pyridines/pharmacology ; Rats ; Rats, Sprague-Dawley ; Sulfones/chemical synthesis ; Sulfones/chemistry ; Sulfones/pharmacology
Chemical Substances 3-(4-(methylsulfonyl)phenyl)-5-(trifluoromethyl)(2-pyridyl) phenyl ketone ; Cyclooxygenase 2 Inhibitors ; Cyclooxygenase Inhibitors ; Pyridines ; Sulfones ; Carrageenan (9000-07-1) ; Cyclooxygenase 2 (EC 1.14.99.1) ; Prostaglandin-Endoperoxide Synthases (EC 1.14.99.1) ; Dinoprostone (K7Q1JQR04M)
Language English
Publishing date 2005-06-02
Publishing country United States
Document type Journal Article
ZDB-ID 218133-2
ISSN 1520-4804 ; 0022-2623
ISSN (online) 1520-4804
ISSN 0022-2623
DOI 10.1021/jm0582064
Shelf mark
Zs.B 151: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Zs.MB 1: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top